| Value | ₹314.6 Cr |
|---|
BSE filing, NSE: INDSWFTLAB. Summary written from the filing by ALFA Finder's alert engine.
Ind-Swift Laboratories Ltd: key numbers
- Share price
- ₹350.90
- Market cap
- ₹3,051 Cr
- Revenue (annual)
- ₹649.1 Cr
- Net profit (annual)
- ₹43.12 Cr
- P/E (TTM)
- 36.5×Sector 47.2×
- Promoter holding
- 42.93%+0.00% QoQ
- FII holding
- 10.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ind-Swift Laboratories Ltd
All →Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Limited submitted its quarterly monitoring agency report for the period ended September 30, 2026. The report covers the utilization of Rs. 137.20 Crore raised via warrants.
Ind-Swift Laboratories Results Update
Ind-Swift Laboratories reported Q2 FY27 revenue up 50% to ₹234.89 crore and PAT up 3.5x to ₹31.03 crore. Operating EBITDA margin rose to 18.02%.
Ind-Swift Laboratories Q2 FY27 Results: Net Profit ₹34.2 Cr, Up 327.5% YoY
Ind-Swift Laboratories Ltd reported revenue from operations of ₹240.5 Cr (+51.6% YoY) and net profit of ₹34.2 Cr (+327.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹34.2 Cr · +327.5% YoY
Ind-Swift Laboratories Board Meeting Date
Ind-Swift Laboratories Ltd. scheduled a board meeting for October 29, 2026, to consider and approve the standalone and consolidated financial results for the quarter and half-year.
Ind-Swift Laboratories Convertible Warrants
Essix Biosciences Limited acquired 14,00,000 equity shares of Ind-Swift Laboratories Limited following the conversion of fully convertible warrants. The company disclosed this under SEBI regulations.
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 14,00,000 equity shares upon conversion of warrants at Rs. 196 each. The allotment follows a previously approved preferential issue.
- Value
- ₹27.44 Cr
Other convertible warrants announcements
All →Regency Fincorp Convertible Warrants
Regency Fincorp received BSE listing approval for 28,12,120 shares issued to non-promoters on warrant conversion. Trading approval awaits depository credit and further exchange filings.
CP Capital Convertible Warrants
CP Capital's EGM approved amending the articles to enable warrant issuance and issuing up to 1,645,000 convertible warrants to promoters. Both resolutions passed with over 99% support.
Abhinav Leasing & Finance Convertible Warrants
Abhinav Leasing allotted 6 crore convertible warrants to four non-promoter entities at INR 1 each. The board-approved allotment raised INR 6 Crore in cash.
- Value
- ₹6.00 Cr
Aanchal Ispat Convertible Warrants
Aanchal Ispat promoter Mukesh Goel acquired 7,26,829 fully convertible warrants at ₹82 each via preferential allotment, raising ~₹5.96 Crore. His overall stake rose to 67.37%.
- Value
- ₹5.96 Cr
Rajkamal Synthetics Convertible Warrants
Rajkamal Synthetics disclosed forfeiture of 68,83,000 outstanding warrants issued on preferential basis in February 2025, after the conversion window closed on 13 August 2026. The filing is treated as compliance under SEBI Listing Regulations.
CP Capital Convertible Warrants
CP Capital's EGM took up an Articles amendment and up to 16,45,000 convertible warrants for promoter group. Voting results are pending; no issue price is stated.